Abstract
Lead-time is the time by which diagnosis is anticipated by screening/surveillance with respect to the symptomatic detection of a disease. Any screening program, including surveillance for hepatocellular carcinoma (HCC), is subject to lead-time bias. Data regarding lead-time for HCC are lacking. Aims of the present study were to calculate lead-time and to assess its impact on the benefit obtainable from the surveillance of cirrhotic patients.
Lingua originale | English |
---|---|
pagine (da-a) | 333-341 |
Numero di pagine | 9 |
Rivista | Journal of Hepatology |
Volume | 61 |
DOI | |
Stato di pubblicazione | Pubblicato - 2014 |
Keywords
- Cirrhosis
- Hepatocellular carcinoma
- Lead-time bias
- Surveillance